Angus W. Jeffrey - Publications

From pressure to prognosis: establishing a common language for portal hypertension in advanced chronic liver disease.

Journal: Gut

Published: June 25, 2026

Outcomes of first and further decompensation events in advanced chronic liver disease: a multi-centre competing risks analysis.

Journal: Hepatology international

Published: February 10, 2026

Noninvasive Prediction of Decompensation in Compensated Advanced Chronic Liver Disease and a Liver Stiffness From 15 to 25 kPa.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: December 28, 2025

Non-Invasive Prediction of Decompensation in Compensated Advanced Chronic Liver Disease and a Liver Stiffness from 15 to 25 kPa.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: December 28, 2025

Noninvasive Prediction Models of First Decompensation in Compensated Advanced Chronic Liver Disease: A Meta-Analysis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 14, 2025

The Portal Hypertension Decompensation Score: A Validated Predictive Model of Liver Decompensation Related to Portal Hypertension.

Journal: The American journal of gastroenterology

Published: April 13, 2025

Analysis of the impact of female sex and muscle mass on serum creatinine and waitlist priority for liver transplantation.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: January 18, 2025

Comparing Long-Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern.

Journal: Journal of gastroenterology and hepatology

Published: October 25, 2024

Letter to the Editor: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.

Journal: Hepatology (Baltimore, Md.)

Published: December 03, 2023

Recent advances in fibrosis assessment for metabolic dysfunction-associated fatty liver disease.

Journal: Alimentary pharmacology & therapeutics

Published: August 26, 2023

Safety and efficacy of transitioning inflammatory bowel disease patients from intravenous to subcutaneous infliximab: a single-center real-world experience.

Journal: Annals of gastroenterology

Published: March 17, 2023

Combination therapy is not associated with improved rates of clinical or endoscopic remission in patients with inflammatory bowel disease treated with ustekinumab or vedolizumab: a retrospective study.

Journal: Annals of gastroenterology

Published: January 25, 2023